Sanofi Healthcare expands Hyderabad Global Hub, boosts capacity to 4,500 staff
Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
Under the deal, Uniphar will serve as LYMPHIR’s exclusive distribution partner across designated Western and Eastern European territories
The surge has been driven largely by COCO stores, with 755 COCO and 165 FOFO outlets added this fiscal year
Anand Chemiceutics serves over 1,500 laboratories, hospitals, and government institutions
CSPC will receive an upfront $1.2 billion from AstraZeneca for access to eight programmes, AI molecular design capabilities, and the LiquidGel platform
The deal brings three high-quality small-molecule drug substance sites into Siegfried’s portfolio
Siegfried plans to grow its exclusive synthesis business in the US by optimizing controlled substance capacity at the Wilmington and nearby Pennsville sites
The company has posted net profit of Rs. 4,064.9 crore for the 9 months period ended December 31, 2025
The deal brings Labcorp’s U.S. portfolio—including biocompatibility, microbiological, and analytical testing, as well as preclinical research—under NAMSA’s roof
Subscribe To Our Newsletter & Stay Updated